Search Results - michael+haffner

1 Results

Sort By:

TARGETING PRAC1 IN CASTRATION RESISTANT PROSTATE CANCER

Therapeutic peptide and biomarkers for castration-resistant prostate cancer (CRPC) Synthetic peptide targeting PRAC1 has been developed for the treatment of CRPC. Prostate cancer is an androgen dependent tumor, and the androgen receptor (AR) drives numerous mechanisms involved in disease progression. The standard therapy for metastatic...

Published: 5/15/2025 | Updated: 7/5/2024 | Inventor(s): Michael Haffner, Jin-Yih Low, Elizabeth Wasmuth, Chitvan Mittal

Keywords(s): Biomarker, Protein / Peptide, Target

Category(s): Diagnostic, Therapeutic